[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global and United States Biologics and Biosimilars Market Research by Company, Type & Application 2013-2025

April 2018 | 120 pages | ID: G7F2ED762D3EN
HeyReport

US$ 2,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original “innovator” products, and can be manufactured when the original product's patent expires.

Market Segment as follows:

By Type
  • Antibody
  • Hormone
  • Growth Factors
  • Others
By Application
  • Tumor
  • Diabetes
  • Cardiovascular
  • Hemophilia
  • Others
By Company
  • Roche
  • Amgen
  • AbbVie
  • Sanofi-Aventis
  • Johnson & Johnson
  • Pfizer
  • Novo Nordisk
  • Eli Lilly
  • Novartis
  • Merck
  • 3sbio
  • Changchun High Tech
  • CP Guojian
  • Biotech
  • Gelgen
  • Innovent
  • Dong Bao
  • Ganlee
  • United Laboratories
The main contents of the report including:

Section 1:
Product definition, type and application, global and United States market overview;
Section 2:
Global and United States Market competition by company;
Section 3:
Global and United States sales revenue, volume and price by type;
Section 4:
Global and United States sales revenue, volume and price by application;
Section 5:
United States export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
SWOT and Porter's Five Forces;
Section 9:
Conclusion.
1 MARKET OVERVIEW

1.1 Market Segment Overview
  1.1.1 Product Definition
  1.1.2 Market by Type
    1.1.2.1 Antibody
    1.1.2.2 Hormone
    1.1.2.3 Growth Factors
    1.1.2.4 Others
  1.1.3 Market by Application
    1.1.3.1 Tumor
    1.1.3.2 Diabetes
    1.1.3.3 Cardiovascular
    1.1.3.4 Hemophilia
    1.1.3.5 Others
1.2 Global and Regional Market Size
  1.2.1 Global Overview
  1.2.2 United States Overview

2 GLOBAL AND REGIONAL MARKET BY COMPANY

2.1 Global
  2.1.1 Global Sales by Company
  2.1.2 Global Price by Company
2.2 United States
  2.2.1 United States Sales by Company
  2.2.2 United States Price by Company

3 GLOBAL AND REGIONAL MARKET BY TYPE

3.1 Global
  3.1.1 Global Sales by Type
  3.1.2 Global Price by Type
3.2 United States
  3.2.1 United States Sales by Type
  3.2.2 United States Price by Type

4 GLOBAL AND REGIONAL MARKET BY APPLICATION

4.1 Global
  4.1.1 Global Sales by Application
  4.1.2 Global Price by Application
4.2 United States
  4.2.1 United States Sales by Application
  4.2.2 United States Price by Application

5 REGIONAL TRADE

5.1 Export
5.2 Import

6 KEY MANUFACTURERS

6.1 Roche
  6.1.2 Company Information
  6.1.2 Product Specifications
  6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 Amgen
  6.2.1 Company Information
  6.2.2 Product Specifications
  6.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.3 AbbVie
  6.3.1 Company Information
  6.3.2 Product Specifications
  6.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.4 Sanofi-Aventis
  6.4.1 Company Information
  6.4.2 Product Specifications
  6.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.5 Johnson & Johnson
  6.5.1 Company Information
  6.5.2 Product Specifications
  6.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.6 Pfizer
  6.6.1 Company Information
  6.6.2 Product Specifications
  6.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.7 Novo Nordisk
  6.7.1 Company Information
  6.7.2 Product Specifications
  6.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.8 Eli Lilly
  6.8.1 Company Information
  6.8.2 Product Specifications
  6.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.9 Novartis
  6.9.1 Company Information
  6.9.2 Product Specifications
  6.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.10 Merck
  6.10.1 Company Information
  6.10.2 Product Specifications
  6.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.11 3sbio
6.12 Changchun High Tech
6.13 CP Guojian
6.14 Biotech
6.15 Gelgen
6.16 Innovent
6.17 Dong Bao
6.18 Ganlee
6.19 United Laboratories

7 INDUSTRY UPSTREAM

7.1 Industry Chain
7.2 Raw Materials

8 MARKET ENVIRONMENT

8.1 SWOT
8.2 Porter's Five Forces

9 CONCLUSION

LIST OF TABLES

Table Global Market Sales Revenue by Company 2013-2017
Table Global Market Sales Revenue Share by Company 2013-2017
Table United States Market Sales Revenue by Company 2013-2017
Table United States Market Sales Revenue Share by Company 2013-2017
Table Global Market Sales Revenue by Type 2013-2017
Table Global Market Sales Revenue Share by Type 2013-2017
Table United States Market Sales Revenue by Type 2013-2017
Table United States Market Sales Revenue Share by Type 2013-2017
Table Global Market Sales Revenue by Application 2013-2017
Table Global Market Sales Revenue Share by Application 2013-2017
Table United States Market Sales Revenue by Application 2013-2017
Table United States Market Sales Revenue Share by Application 2013-2017
Table United States Export 2013-2017 (Million USD)
Table United States Import 2013-2017 (Million USD)
Table Sales Revenue, Cost and Margin of Roche
Table Sales Revenue, Cost and Margin of Amgen
Table Sales Revenue, Cost and Margin of AbbVie
Table Sales Revenue, Cost and Margin of Sanofi-Aventis
Table Sales Revenue, Cost and Margin of Johnson & Johnson
Table Sales Revenue, Cost and Margin of Pfizer
Table Sales Revenue, Cost and Margin of Novo Nordisk
Table Sales Revenue, Cost and Margin of Eli Lilly
Table Sales Revenue, Cost and Margin of Novartis
Table Sales Revenue, Cost and Margin of Merck
Table Sales Revenue, Cost and Margin of 3sbio
Table Sales Revenue, Cost and Margin of Changchun High Tech
Table Sales Revenue, Cost and Margin of CP Guojian
Table Sales Revenue, Cost and Margin of Biotech
Table Sales Revenue, Cost and Margin of Gelgen
Table Sales Revenue, Cost and Margin of Innovent
Table Sales Revenue, Cost and Margin of Dong Bao
Table Sales Revenue, Cost and Margin of Ganlee
Table Sales Revenue, Cost and Margin of United Laboratories

LIST OF FIGURES

Figure Antibody Market Size and CAGR 2013-2017 (Million USD)
Figure Antibody Market Forecast and CAGR 2018-2025 (Million USD)
Figure Hormone Market Size and CAGR 2013-2017 (Million USD)
Figure Hormone Market Forecast and CAGR 2018-2025 (Million USD)
Figure Growth Factors Market Size and CAGR 2013-2017 (Million USD)
Figure Growth Factors Market Forecast and CAGR 2018-2025 (Million USD)
Figure Others Market Size and CAGR 2013-2017 (Million USD)
Figure Others Market Forecast and CAGR 2018-2025 (Million USD)
Figure Tumor Market Size and CAGR 2013-2017 (Million USD)
Figure Tumor Market Forecast and CAGR 2018-2025 (Million USD)
Figure Diabetes Market Size and CAGR 2013-2017 (Million USD)
Figure Diabetes Market Forecast and CAGR 2018-2025 (Million USD)
Figure Cardiovascular Market Size and CAGR 2013-2017 (Million USD)
Figure Cardiovascular Market Forecast and CAGR 2018-2025 (Million USD)
Figure Hemophilia Market Size and CAGR 2013-2017 (Million USD)
Figure Hemophilia Market Forecast and CAGR 2018-2025 (Million USD)
Figure Others Market Size and CAGR 2013-2017 (Million USD)
Figure Others Market Forecast and CAGR 2018-2025 (Million USD)
Figure Global Biologics and Biosimilars Market Size and CAGR 2013-2017 (Million USD)
Figure Global Biologics and Biosimilars Market Forecast and CAGR 2018-2025 (Million USD)
Figure United States Biologics and Biosimilars Market Size and CAGR 2013-2017 (Million USD)
Figure United States Biologics and Biosimilars Market Forecast and CAGR 2018-2025 (Million USD)
Figure Global Market Sales Revenue Share by Company in 2017
Figure United States Market Sales Revenue Share by Company in 2017
Figure Global Market Sales Revenue Share by Type in 2017
Figure United States Market Sales Revenue Share by Type in 2017
Figure Global Market Sales Revenue Share by Application in 2017
Figure United States Market Sales Revenue Share by Application in 2017
Figure Industry Chain Overview
Figure Biologics and Biosimilars SWOT List
Figure Healthcare & Medical Porter's Five Forces


More Publications